Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−15.60 USD
−92.92 M USD
2.56 M USD
2.88 M
About Senti Biosciences, Inc.
Sector
Industry
CEO
Timothy K. Lu
Website
Headquarters
South San Francisco
Founded
2016
FIGI
BBG010WX7ZB3
Senti Biosciences, Inc. is a biotechnology company. It engages in the business of developing next-generation cell and gene therapies engineered with a gene circuit platform technology to fight challenging diseases. The company was founded by Timothy K. Lu, Wilson Wong, and Philip Lee on June 9, 2016 and is headquartered in South San Francisco, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SNTI is 7.14 USD — it has increased by 362.96% in the past 24 hours. Watch Senti Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Senti Biosciences, Inc. stocks are traded under the ticker SNTI.
SNTI stock has risen by 380.77% compared to the previous week, the month change is a 372.97% rise, over the last year Senti Biosciences, Inc. has showed a 65.78% increase.
We've gathered analysts' opinions on Senti Biosciences, Inc. future price: according to them, SNTI price has a max estimate of 10.00 USD and a min estimate of 10.00 USD. Watch SNTI chart and read a more detailed Senti Biosciences, Inc. stock forecast: see what analysts think of Senti Biosciences, Inc. and suggest that you do with its stocks.
SNTI reached its all-time high on Sep 1, 2021 with the price of 105.40 USD, and its all-time low was 1.52 USD and was reached on Aug 7, 2024. View more price dynamics on SNTI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SNTI stock is 50.38% volatile and has beta coefficient of 2.06. Track Senti Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Senti Biosciences, Inc. there?
Today Senti Biosciences, Inc. has the market capitalization of 45.89 M, it has decreased by −1.40% over the last week.
Yes, you can track Senti Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Senti Biosciences, Inc. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
SNTI net income for the last quarter is −28.87 M USD, while the quarter before that showed −11.20 M USD of net income which accounts for −157.66% change. Track more Senti Biosciences, Inc. financial stats to get the full picture.
No, SNTI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 4, 2024, the company has 48.00 employees. See our rating of the largest employees — is Senti Biosciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Senti Biosciences, Inc. EBITDA is −57.12 M USD, and current EBITDA margin is −2.40 K%. See more stats in Senti Biosciences, Inc. financial statements.
Like other stocks, SNTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Senti Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Senti Biosciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Senti Biosciences, Inc. stock shows the buy signal. See more of Senti Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.